nandrolone has been researched along with Menstruation, Painful in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.17) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 11 (45.83) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y; Ji, M; Jiao, X; Li, J; Li, Q; Wang, G; Yuan, M | 1 |
| Alfano, P; Audino, P; Incandela, D; Maiorana, A; Marcantonio, S; Mercurio, A; Minneci, G | 1 |
| Dietrich, H; Imesch, P; Knobel, C; Merki-Feld, GS; Metzler, J; Muendane, A; Neumeier, MS; Niggli, A; Portmann, L | 1 |
| Arena, A; Aru, AC; Borghese, G; Caroli, M; Casadio, P; Del Forno, S; Lenzi, J; Meriggiola, MC; Orsini, B; Paradisi, R; Raimondo, D; Seracchioli, R; Verrelli, L | 1 |
| Hayashi, K; Kanda, S; Osuga, Y | 3 |
| Yunker, AC | 1 |
| Angioni, S; Barbasetti Di Prun, A; Barbera, V; Belloni, GM; Pietropaolo, G; Pino, I; Vignali, M | 1 |
| Abdelhakim, AM; Ahmed, SA; AlAmodi, AA; Ali, AS; Ashour, K; El Kattan, EAM; Elsherbini, M; Fathi, M; Haggag, H; Keshta, NHA; Salah, DM; Samy, A; Shareef, MA; Shatat, HBAE; Sileem, SA; Taher, A | 1 |
| Ainsworth, AJ; Cope, AG; Stewart, EA | 1 |
| Akkaya, H; Cagli, F; Tayyar, AT; Tutus, S; Uysal, G | 1 |
| Mizunuma, H; Ota, K; Shiraishi, S; Takahashi, T | 1 |
| Martini, E; Nappi, RE; Sances, G; Santamaria, V; Spinillo, A; Tassorelli, C; Terreno, E; Tonani, S | 1 |
| Mellinger, U; Parke, S; Petraglia, F; Römer, T; Serrani, M | 1 |
| Cagnacci, A; Grandi, G; Napolitano, A; Palma, F; Xholli, A | 1 |
| Graziottin, A | 1 |
| Harada, T; Taniguchi, F | 1 |
| Faustmann, T; Gerlinger, C; Marr, J; Seitz, C; Strowitzki, T | 1 |
| BISHOP, PM | 1 |
| ANTOINE, T | 1 |
| KAISER, R | 1 |
| MCGARRITY, KA | 1 |
| Hashmi, HA; Mustafa, R | 1 |
4 review(s) available for nandrolone and Menstruation, Painful
| Article | Year |
|---|---|
Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials.
Topics: Contraceptive Agents, Hormonal; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hydrocarbons, Fluorinated; Levonorgestrel; Nandrolone; Network Meta-Analysis; Pelvic Pain; Pyrimidines; Randomized Controlled Trials as Topic; Visual Analog Scale | 2021 |
Current and Future Medical Therapies for Adenomyosis.
Topics: Adenomyosis; Dysmenorrhea; Female; Hormone Antagonists; Humans; Levonorgestrel; Menorrhagia; Nandrolone; Pain Measurement; Quality of Life | 2020 |
The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Drug Combinations; Dysmenorrhea; Estradiol; Estrogens; Female; Gastrointestinal Diseases; Headache; Humans; Inflammation; Menstruation; Mood Disorders; Nandrolone; Pelvic Pain; Progesterone; Quality of Life | 2016 |
Dienogest: a new therapeutic agent for the treatment of endometriosis.
Topics: Animals; Dysmenorrhea; Endometriosis; Female; Hormone Antagonists; Humans; Male; Nandrolone; Ovary; Rabbits; Randomized Controlled Trials as Topic; Treatment Outcome; Uterine Hemorrhage | 2010 |
6 trial(s) available for nandrolone and Menstruation, Painful
| Article | Year |
|---|---|
Evaluation of the efficacy, safety, and clinically recommended dose of dienogest in the treatment of primary dysmenorrhea: a randomized, double-blind, multicenter, placebo-controlled study.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Dysmenorrhea; Female; Hemorrhage; Hormone Antagonists; Humans; Nandrolone; Treatment Outcome | 2020 |
Long-term use of dienogest for the treatment of primary and secondary dysmenorrhea.
Topics: Adult; Drug Administration Schedule; Dysmenorrhea; Female; Hormone Antagonists; Humans; Menstruation Disturbances; Nandrolone; Severity of Illness Index; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2020 |
A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea.
Topics: Administration, Oral; Adult; Back Pain; Dosage Forms; Double-Blind Method; Dysmenorrhea; Female; Humans; Japan; Nandrolone; Pain Measurement; Pelvic Pain; Placebos; Treatment Outcome; Young Adult | 2020 |
A comparison of two different oral contraceptives in patients with severe primary dysmenorrhoea.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral; Drug Combinations; Dysmenorrhea; Estradiol; Ethinyl Estradiol; Female; Humans; Nandrolone; Pain Measurement; Pelvic Pain; Prospective Studies; Pulsatile Flow; Treatment Outcome; Ultrasonography, Doppler; Uterine Artery; Young Adult | 2018 |
Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
Topics: Adolescent; Adult; Double-Blind Method; Drug Combinations; Dysmenorrhea; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Nandrolone; Time Factors; Treatment Outcome; Young Adult | 2014 |
Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Dysmenorrhea; Endometriosis; Estrogens; Female; Humans; Leuprolide; Middle Aged; Nandrolone; Pelvic Pain; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Young Adult | 2012 |
14 other study(ies) available for nandrolone and Menstruation, Painful
| Article | Year |
|---|---|
A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
Topics: Adenomyosis; Cohort Studies; Dysmenorrhea; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Nandrolone | 2022 |
Quality of life and clinical factors in women with endometriosis, the role of dienogest vs EE/dienogest over time: a single-center study.
Topics: Dysmenorrhea; Endometriosis; Female; Humans; Nandrolone; Quality of Life; Treatment Outcome | 2023 |
Endometriosis features and dienogest tolerability in women with depression: a case-control study.
Topics: Case-Control Studies; Depression; Dysmenorrhea; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain | 2023 |
Dienogest alone or dienogest combined with estrogens in the treatment of ovarian endometriomas, that is the question. A retrospective cohort study.
Topics: Dysmenorrhea; Dysuria; Endometriosis; Estradiol; Estrogens; Female; Humans; Nandrolone; Retrospective Studies | 2023 |
Primary dysmenorrhea: new dose of an old medicine offers more options.
Topics: Double-Blind Method; Dysmenorrhea; Female; Humans; Medicine; Nandrolone | 2020 |
Effect of Dienogest therapy on the size of the endometrioma.
Topics: Adult; Dysmenorrhea; Dyspareunia; Endometriosis; Endometrium; Female; Humans; Italy; Middle Aged; Nandrolone; Organ Size; Pelvic Pain; Peritoneal Diseases; Prospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2020 |
Combination of microwave endometrial ablation and postoperative dienogest administration is effective for treating symptomatic adenomyosis.
Topics: Adenomyosis; Adult; Combined Modality Therapy; Dysmenorrhea; Endometrial Ablation Techniques; Female; Hormone Antagonists; Humans; Menorrhagia; Microwaves; Middle Aged; Nandrolone; Outcome Assessment, Health Care; Retrospective Studies | 2018 |
Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Topics: Adult; Analgesics; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Dysmenorrhea; Estradiol; Female; Humans; Italy; Menstruation; Migraine Disorders; Nandrolone; Pilot Projects; Prospective Studies; Treatment Outcome | 2013 |
Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
Topics: Adult; Contraceptives, Oral, Hormonal; Drug Combinations; Dysmenorrhea; Endometriosis; Estradiol; Female; Hospitals, University; Humans; Italy; Nandrolone; Pain Measurement; Patient Preference; Pelvic Pain; Pilot Projects; Prospective Studies; Quality of Life; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2015 |
The use of oral progestins in the treatment of dysmenorrhoea.
Topics: Dysmenorrhea; Female; Humans; Nandrolone; Progesterone; Progestins; Testosterone | 1962 |
[Oral gestagenic therapy].
Topics: Contraception; Dysmenorrhea; Endometriosis; Female; Humans; Nandrolone; Progestins | 1963 |
[HORMONAL INHIBITION OF OVULATION. METHODS, INDICATIONS, SIDE-EFFECTS, RESULTS].
Topics: Contraceptive Agents; Contraceptives, Oral; Dysmenorrhea; Endometriosis; Ethinyl Estradiol; Female; Humans; Infertility; Infertility, Female; Nandrolone; Ovulation; Pregnanediol; Premenstrual Syndrome; Progesterone; Progestins; Toxicology | 1963 |
HORMONE THERAPY IN GYNAECOLOGY.
Topics: Androgens; Breast Diseases; Drug Therapy; Dysmenorrhea; Endometriosis; Female; Genital Diseases, Female; Gynecology; Humans; Hydroxyprogesterones; Hypertrichosis; Infertility; Infertility, Female; Medroxyprogesterone; Menorrhagia; Mestranol; Metrorrhagia; Nandrolone; Norethindrone; Norethynodrel; Ovulation; Premenstrual Syndrome; Progesterone; Progestins; Testosterone; Uterine Neoplasms | 1964 |
Drug-induced hirsutism.
Topics: Adult; Anabolic Agents; Dysmenorrhea; Female; Hirsutism; Humans; Nandrolone; Nandrolone Decanoate | 2006 |